Robert Langer

What is he best known for?

The fields of study he is best known for:

• Internal medicine
• Enzyme
• Gene

His primary areas of study are Nanotechnology, Drug delivery, Tissue engineering, Polymer and Biomedical engineering. In general Nanotechnology, his work in Nanoparticle, Nanomedicine and Microfluidics is often linked to Extramural linking many areas of study. His Drug delivery research is multidisciplinary, incorporating perspectives in Drug and Transdermal.

His Tissue engineering research is multidisciplinary, relying on both Cell culture, Biomaterial, Biophysics, Anatomy and Transplantation. His study in Polymer is interdisciplinary in nature, drawing from both Biodegradation, Chemical engineering and Polymer chemistry. His work in Biomedical engineering addresses subjects such as In vivo, which are connected to disciplines such as Pharmacology.

His most cited work include:

• Nanocarriers as an emerging platform for cancer therapy (5854 citations)
• Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial (3739 citations)
• Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology† (2734 citations)

What are the main themes of his work throughout his whole career to date?

Robert Langer mostly deals with Nanotechnology, Polymer, Biomedical engineering, Drug delivery and In vivo. His work is connected to Nanoparticle and Microfluidics, as a part of Nanotechnology. The Polymer study combines topics in areas such as Chemical engineering, Controlled release and Polymer chemistry.

A large part of his Biomedical engineering studies is devoted to Tissue engineering. Many of his studies on Drug delivery apply to Pharmacology as well. His studies link In vitro with In vivo.

He most often published in these fields:

• Nanotechnology (16.02%)
• Polymer (16.02%)
• Biomedical engineering (15.54%)

What were the highlights of his more recent work (between 2014-2021)?

• Drug delivery (14.26%)
• Biomedical engineering (15.54%)
• In vivo (11.34%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Drug delivery, Biomedical engineering, In vivo, Pharmacology and Nanotechnology. His Drug delivery study frequently links to adjacent areas such as Controlled release. He combines subjects such as Biophysics, Cancer research and Messenger RNA with his study of In vivo.

His Cancer research research incorporates themes from Cancer and Metastasis. Robert Langer mostly deals with Drug in his studies of Pharmacology. His Nanotechnology study combines topics in areas such as Self-healing hydrogels and Polymer.

Between 2014 and 2021, his most popular works were:

• Physical and mechanical properties of PLA, and their functions in widespread applications - A comprehensive review. (734 citations)
• Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (504 citations)
• Emerging Frontiers in Drug Delivery (442 citations)

In his most recent research, the most cited papers focused on:

• Internal medicine
• Enzyme
• Gene

His primary scientific interests are in Drug delivery, In vivo, Nanotechnology, Pharmacology and Immunology. His research integrates issues of Biomolecule and Inflammatory bowel disease in his study of Drug delivery. His study focuses on the intersection of In vivo and fields such as Molecular biology with connections in the field of Transfection.

Robert Langer focuses mostly in the field of Nanotechnology, narrowing it down to topics relating to Polymer and, in certain cases, Polymer chemistry. While the research belongs to areas of Pharmacology, he spends his time largely on the problem of Diabetes mellitus, intersecting his research to questions surrounding Transplantation. The various areas that Robert Langer examines in his Drug study include Dosage form and Controlled release.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.